Literature DB >> 16682967

Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in Type II diabetic ZDF rats.

Matthew P Burnham1, Ian T Johnson, Arthur H Weston.   

Abstract

We have examined the relative contributions of small- and intermediate-conductance Ca(2+)-activated K(+) channels (SK(Ca) and IK(Ca)) to the endothelium-derived hyperpolarizing factor (EDHF) pathway response in small mesenteric arteries of Zucker Diabetic Fatty (ZDF) rats, before and after the development of Type II diabetes, together with Lean controls. Smooth muscle membrane potential was recorded using sharp microelectrodes in the presence of 10 microM indomethacin plus 100 microM N(omega)-nitro-L-arginine. SK(Ca) was selectively inhibited with 100 nM apamin, whereas IK(Ca) was blocked with 10 microM TRAM-39 (2-(2-chlorophenyl)-2,2-diphenylacetonitrile). Resting membrane potentials were similar in arteries from 17- to 20-week-old control and diabetic rats (approximately -54 mV). Responses elicited by 1 and 10 microM acetylcholine (ACh) were significantly smaller in the diabetic group (e.g. hyperpolarizations to -69.5 +/- 0.8 mV (ZDF; n = 12) and -73.2 +/- 0.6 mV (Lean; n = 12; P < 0.05) evoked by 10 microM ACh). The IK(Ca)-mediated components of the ACh responses were comparable between groups (hyperpolarizations to approximately -65 mV on exposure to 10 microM ACh). However, SK(Ca)-mediated responses were significantly reduced in the diabetic group (hyperpolarizations to -63.1 +/- 1.0 mV (ZDF; n = 6) and -71.5 +/- 1.2 mV (Lean; n = 6; P < 0.05) on exposure to 10 microM ACh. Impaired ACh responses were not observed in arteries from 5- to 6-week-old (pre-diabetic) animals. SK(Ca) subunit mRNA expression was increased in the diabetic group. The EDHF pathway, especially the SK(Ca)-mediated response, is impaired in Type II diabetic ZDF rats without a reduction in channel gene expression. These results may be particularly relevant to the microvascular complications of diabetes. The functional separation of SK(Ca) and IK(Ca) pathways is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682967      PMCID: PMC1751791          DOI: 10.1038/sj.bjp.0706748

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  EDHF: bringing the concepts together.

Authors:  Rudi Busse; Gillian Edwards; Michel Félétou; Ingrid Fleming; Paul M Vanhoutte; Arthur H Weston
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

2.  EDHF is not K+ but may be due to spread of current from the endothelium in guinea pig arterioles.

Authors:  H A Coleman; M Tare; H C Parkington
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

Review 3.  Diabetes and endothelial dysfunction: a clinical perspective.

Authors:  J Calles-Escandon; M Cipolla
Journal:  Endocr Rev       Date:  2001-02       Impact factor: 19.871

4.  Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3.

Authors:  E T Barfod; A L Moore; S D Lidofsky
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

5.  Activation of endothelial cell IK(Ca) with 1-ethyl-2-benzimidazolinone evokes smooth muscle hyperpolarization in rat isolated mesenteric artery.

Authors:  S D Walker; K A Dora; N T Ings; G J Crane; C J Garland
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Pharmacological modulation of SK3 channels.

Authors:  M Grunnet; T Jespersen; K Angelo; C Frøkjaer-Jensen; D A Klaerke; S P Olesen; B S Jensen
Journal:  Neuropharmacology       Date:  2001-06       Impact factor: 5.250

7.  Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.

Authors:  Sachi Hoshi; Yujing Shu; Fusayo Yoshida; Tomoko Inagaki; Jiro Sonoda; Teruo Watanabe; Ken-ichi Nomoto; Michio Nagata
Journal:  Lab Invest       Date:  2002-01       Impact factor: 5.662

8.  Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.

Authors:  Lawrence J Coppey; Jill S Gellett; Eric P Davidson; Joyce A Dunlap; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2002 Jan-Feb       Impact factor: 4.876

9.  Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF.

Authors:  M P Burnham; R Bychkov; M Félétou; G R Richards; P M Vanhoutte; A H Weston; G Edwards
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

10.  Pharmacological and molecular characterisation of SK3 channels in the TE671 human medulloblastoma cell line.

Authors:  Corrado Carignani; Renza Roncarati; Rebecca Rimini; Georg C Terstappen
Journal:  Brain Res       Date:  2002-06-07       Impact factor: 3.252

View more
  32 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

Review 2.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

3.  KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Authors:  Serge Simonet; Marc Isabelle; Mélanie Bousquenaud; Nicolas Clavreul; Michel Félétou; Christine Vayssettes-Courchay; Tony J Verbeuren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

4.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

Review 5.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

Review 6.  Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Authors:  Ivica Grgic; Brajesh P Kaistha; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

7.  Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity.

Authors:  Attila Feher; Ibolya Rutkai; Timea Beleznai; Zoltan Ungvari; Anna Csiszar; Istvan Edes; Zsolt Bagi
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

8.  NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats.

Authors:  E Brøndum; H Kold-Petersen; U Simonsen; Christian Aalkjaer
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

Review 9.  Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.

Authors:  Ralf Köhler; Brajesh P Kaistha; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2010-02       Impact factor: 6.902

10.  Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains.

Authors:  M Absi; M P Burnham; A H Weston; E Harno; M Rogers; G Edwards
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.